ArticleBMJ open2019

Safety of switching from vitamin K antagonist to non-vitamin K antagonist oral anticoagulant in frail elderly with atrial fibrillation: rationale and design of the FRAIL-AF randomised controlled trial.

Linda P T Joosten et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.